DG Shah, secretary-general, Indian Pharmaceutical Alliance explains to CNBC-TV18 that the new pharma pricing adopted by the government would offer less effective drugs to consumers, stifle the growth of research and development in India and stall overseas investment.
first published: Nov 22, 2012 10:31 pm
A collection of the most-viewed Moneycontrol videos.
Live: Nifty reclaims 25,300, registers over 1% gain this week | Closing Bell
Live: Will Nifty bulls aim to break 25,250 after strong TCS Q2? | Opening Bell
TCS Q2 Earnings Live: Margin, Revenue Beat Street Estimates
Live: Nifty reclaims 25,100 ahead of TCS Q2 results; pharma, metals shine | Closing Bell
